Microbiological and Organizational Impact of the Use of Bacteriologically Controlled Water in COLOscopy
Launched by UNIVERSITY HOSPITAL, BORDEAUX · Nov 12, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at the safety of using specially treated water during colonoscopy procedures. Colonoscopy is a test that helps doctors look inside the colon to check for problems. The goal of the study is to ensure that the water used for cleaning equipment during the procedure does not get contaminated with bacteria from patients. This is important because the study aims to confirm that using this type of water is safe for all patients undergoing colonoscopy.
To be eligible for this trial, patients must be scheduled for a colonoscopy on specific days and times and should be adults over the age of 18. They also need to be part of a health insurance plan. However, pregnant women, those under guardianship, or those needing emergency procedures will not be included. If you participate, you can expect to help researchers understand how to improve colonoscopy safety practices, which could benefit future patients. The trial is not yet recruiting participants, so it’s still in the planning stages.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients with a colonoscopy indication whose examination is scheduled in room 4, on a Monday and Tuesday shift (8:30 a.m. - 1:30 p.m.)
- • Male or female of legal age at the time the colonoscopy is ordered
- • Patient willing to participate in the study
- • Person affiliated with or benefiting from a social security plan
- Exclusion Criteria:
- • Pregnant woman
- • Patient of legal age under guardianship or protected person
- • Patient requiring indigo-carmine chromoendoscopy
- • Patient requiring an emergency colonoscopy
- • Patient not affiliated to the social security system
About University Hospital, Bordeaux
The University Hospital of Bordeaux is a leading academic medical center dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, the institution integrates cutting-edge scientific inquiry with patient care, fostering an environment that encourages collaboration among multidisciplinary teams. With a commitment to improving treatment outcomes and enhancing patient safety, the University Hospital of Bordeaux plays a pivotal role in the development of new therapies and medical technologies, contributing significantly to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Arthur BERGER
Principal Investigator
University Hospital, Bordeaux
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported